Loading…

Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival

The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular and interventional radiology 2008-09, Vol.31 (5), p.948-956
Main Authors: Veltri, Andrea, Sacchetto, Paola, Tosetti, Irene, Pagano, Eva, Fava, Cesare, Gandini, Giovanni
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3
cites cdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3
container_end_page 956
container_issue 5
container_start_page 948
container_title Cardiovascular and interventional radiology
container_volume 31
creator Veltri, Andrea
Sacchetto, Paola
Tosetti, Irene
Pagano, Eva
Fava, Cesare
Gandini, Giovanni
description The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique ( p  = 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions >3 cm ( p  3 cm ( p  = 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated.
doi_str_mv 10.1007/s00270-008-9362-0
format article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21426348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69541564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</originalsourceid><addsrcrecordid>eNp1kVFrFDEUhQdR7Fr9Ab5IUPBt9N5MJpnxrSytCiuKW8G3kMnc0ZRsUpOZhe2vN2UXCoIQuIF85-RcTlW9RHiHAOp9BuAKaoCu7hvJa3hUrVA05dLJn4-rFaASNbYtnlXPcr4BwLbj7dPqDLsWZIv9qrr7bkYXp0R_Fgr2wC4Gb2YXA4sTW0cfE9nZeLZxe0rsC80ml0P5A9vujPds6-6IXZl9TGbwB_Yt0ejsnNk12d_BFU92OU3FosgD5cxMGNl2SXu3N_559WQyPtOL0zyvflxdXq8_1ZuvHz-vLza1bXo11x0oUCMNQ6_EMNihFYSjEoCTlUJSb-TYSCWFsGLCnoMiVAomOQqpkHpqzqs3R9-YZ6ezdXMJZ2MIJZfmKLhsRFeot0fqNsWSO89657Il702guGQt-1ZgK0UBX_8D3sQlhbKB5lw1giP2BcIjZFPMOdGkb5PbmXTQCPq-O33sTpfu9H13Gorm1cl4GXY0PihOZRWAH4FcnsIvSg8__9_1L1NspHo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227342119</pqid></control><display><type>article</type><title>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</title><source>Springer Nature</source><creator>Veltri, Andrea ; Sacchetto, Paola ; Tosetti, Irene ; Pagano, Eva ; Fava, Cesare ; Gandini, Giovanni</creator><creatorcontrib>Veltri, Andrea ; Sacchetto, Paola ; Tosetti, Irene ; Pagano, Eva ; Fava, Cesare ; Gandini, Giovanni</creatorcontrib><description>The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique ( p  = 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions &gt;3 cm ( p  &lt; 0.0001). Survival rates at 1, 3, and 5 years were 91%, 54%, and 33%, respectively, from the diagnosis of MTS and 79%, 38%, and 22%, respectively, from RFA. Mean survival time from RFA was 31.5 months, 36.2 in patients with main MTS ≤3 cm and 23.2 in those with at least one lesion &gt;3 cm ( p  = 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-008-9362-0</identifier><identifier>PMID: 18506519</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>ABLATION ; Adenocarcinoma - mortality ; Adenocarcinoma - secondary ; Adenocarcinoma - therapy ; Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; BODY ; Cardiology ; Catheter Ablation - methods ; Chi-Square Distribution ; Clinical Investigation ; Cohort Studies ; Colorectal Neoplasms - mortality ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - therapy ; DIGESTIVE SYSTEM ; ELECTROMAGNETIC RADIATION ; Female ; Follow-Up Studies ; GLANDS ; Humans ; Imaging ; Kaplan-Meier Estimate ; LIVER ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Liver Neoplasms - secondary ; Liver Neoplasms - surgery ; Male ; MEDICINE ; Medicine &amp; Public Health ; METASTASES ; Middle Aged ; Minimally Invasive Surgical Procedures - methods ; Multivariate Analysis ; Neoplasm Staging ; Nuclear Medicine ; ORGANS ; Predictive Value of Tests ; Quality of Life ; RADIATIONS ; Radiology ; RADIOLOGY AND NUCLEAR MEDICINE ; RADIOWAVE RADIATION ; Retrospective Studies ; Risk Assessment ; SURGERY ; Survival Analysis ; SURVIVAL TIME ; Treatment Outcome ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2008-09, Vol.31 (5), p.948-956</ispartof><rights>Springer Science+Business Media, LLC 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</citedby><cites>FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18506519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21426348$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Veltri, Andrea</creatorcontrib><creatorcontrib>Sacchetto, Paola</creatorcontrib><creatorcontrib>Tosetti, Irene</creatorcontrib><creatorcontrib>Pagano, Eva</creatorcontrib><creatorcontrib>Fava, Cesare</creatorcontrib><creatorcontrib>Gandini, Giovanni</creatorcontrib><title>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique ( p  = 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions &gt;3 cm ( p  &lt; 0.0001). Survival rates at 1, 3, and 5 years were 91%, 54%, and 33%, respectively, from the diagnosis of MTS and 79%, 38%, and 22%, respectively, from RFA. Mean survival time from RFA was 31.5 months, 36.2 in patients with main MTS ≤3 cm and 23.2 in those with at least one lesion &gt;3 cm ( p  = 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated.</description><subject>ABLATION</subject><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - secondary</subject><subject>Adenocarcinoma - therapy</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>BODY</subject><subject>Cardiology</subject><subject>Catheter Ablation - methods</subject><subject>Chi-Square Distribution</subject><subject>Clinical Investigation</subject><subject>Cohort Studies</subject><subject>Colorectal Neoplasms - mortality</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - therapy</subject><subject>DIGESTIVE SYSTEM</subject><subject>ELECTROMAGNETIC RADIATION</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>GLANDS</subject><subject>Humans</subject><subject>Imaging</subject><subject>Kaplan-Meier Estimate</subject><subject>LIVER</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - surgery</subject><subject>Male</subject><subject>MEDICINE</subject><subject>Medicine &amp; Public Health</subject><subject>METASTASES</subject><subject>Middle Aged</subject><subject>Minimally Invasive Surgical Procedures - methods</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Staging</subject><subject>Nuclear Medicine</subject><subject>ORGANS</subject><subject>Predictive Value of Tests</subject><subject>Quality of Life</subject><subject>RADIATIONS</subject><subject>Radiology</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RADIOWAVE RADIATION</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>SURGERY</subject><subject>Survival Analysis</subject><subject>SURVIVAL TIME</subject><subject>Treatment Outcome</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp1kVFrFDEUhQdR7Fr9Ab5IUPBt9N5MJpnxrSytCiuKW8G3kMnc0ZRsUpOZhe2vN2UXCoIQuIF85-RcTlW9RHiHAOp9BuAKaoCu7hvJa3hUrVA05dLJn4-rFaASNbYtnlXPcr4BwLbj7dPqDLsWZIv9qrr7bkYXp0R_Fgr2wC4Gb2YXA4sTW0cfE9nZeLZxe0rsC80ml0P5A9vujPds6-6IXZl9TGbwB_Yt0ejsnNk12d_BFU92OU3FosgD5cxMGNl2SXu3N_559WQyPtOL0zyvflxdXq8_1ZuvHz-vLza1bXo11x0oUCMNQ6_EMNihFYSjEoCTlUJSb-TYSCWFsGLCnoMiVAomOQqpkHpqzqs3R9-YZ6ezdXMJZ2MIJZfmKLhsRFeot0fqNsWSO89657Il702guGQt-1ZgK0UBX_8D3sQlhbKB5lw1giP2BcIjZFPMOdGkb5PbmXTQCPq-O33sTpfu9H13Gorm1cl4GXY0PihOZRWAH4FcnsIvSg8__9_1L1NspHo</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Veltri, Andrea</creator><creator>Sacchetto, Paola</creator><creator>Tosetti, Irene</creator><creator>Pagano, Eva</creator><creator>Fava, Cesare</creator><creator>Gandini, Giovanni</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20080901</creationdate><title>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</title><author>Veltri, Andrea ; Sacchetto, Paola ; Tosetti, Irene ; Pagano, Eva ; Fava, Cesare ; Gandini, Giovanni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>ABLATION</topic><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - secondary</topic><topic>Adenocarcinoma - therapy</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>BODY</topic><topic>Cardiology</topic><topic>Catheter Ablation - methods</topic><topic>Chi-Square Distribution</topic><topic>Clinical Investigation</topic><topic>Cohort Studies</topic><topic>Colorectal Neoplasms - mortality</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - therapy</topic><topic>DIGESTIVE SYSTEM</topic><topic>ELECTROMAGNETIC RADIATION</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>GLANDS</topic><topic>Humans</topic><topic>Imaging</topic><topic>Kaplan-Meier Estimate</topic><topic>LIVER</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - surgery</topic><topic>Male</topic><topic>MEDICINE</topic><topic>Medicine &amp; Public Health</topic><topic>METASTASES</topic><topic>Middle Aged</topic><topic>Minimally Invasive Surgical Procedures - methods</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Staging</topic><topic>Nuclear Medicine</topic><topic>ORGANS</topic><topic>Predictive Value of Tests</topic><topic>Quality of Life</topic><topic>RADIATIONS</topic><topic>Radiology</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RADIOWAVE RADIATION</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>SURGERY</topic><topic>Survival Analysis</topic><topic>SURVIVAL TIME</topic><topic>Treatment Outcome</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veltri, Andrea</creatorcontrib><creatorcontrib>Sacchetto, Paola</creatorcontrib><creatorcontrib>Tosetti, Irene</creatorcontrib><creatorcontrib>Pagano, Eva</creatorcontrib><creatorcontrib>Fava, Cesare</creatorcontrib><creatorcontrib>Gandini, Giovanni</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veltri, Andrea</au><au>Sacchetto, Paola</au><au>Tosetti, Irene</au><au>Pagano, Eva</au><au>Fava, Cesare</au><au>Gandini, Giovanni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>31</volume><issue>5</issue><spage>948</spage><epage>956</epage><pages>948-956</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique ( p  = 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions &gt;3 cm ( p  &lt; 0.0001). Survival rates at 1, 3, and 5 years were 91%, 54%, and 33%, respectively, from the diagnosis of MTS and 79%, 38%, and 22%, respectively, from RFA. Mean survival time from RFA was 31.5 months, 36.2 in patients with main MTS ≤3 cm and 23.2 in those with at least one lesion &gt;3 cm ( p  = 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>18506519</pmid><doi>10.1007/s00270-008-9362-0</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0174-1551
ispartof Cardiovascular and interventional radiology, 2008-09, Vol.31 (5), p.948-956
issn 0174-1551
1432-086X
language eng
recordid cdi_osti_scitechconnect_21426348
source Springer Nature
subjects ABLATION
Adenocarcinoma - mortality
Adenocarcinoma - secondary
Adenocarcinoma - therapy
Adult
Aged
Aged, 80 and over
Analysis of Variance
BODY
Cardiology
Catheter Ablation - methods
Chi-Square Distribution
Clinical Investigation
Cohort Studies
Colorectal Neoplasms - mortality
Colorectal Neoplasms - pathology
Colorectal Neoplasms - therapy
DIGESTIVE SYSTEM
ELECTROMAGNETIC RADIATION
Female
Follow-Up Studies
GLANDS
Humans
Imaging
Kaplan-Meier Estimate
LIVER
Liver Neoplasms - mortality
Liver Neoplasms - pathology
Liver Neoplasms - secondary
Liver Neoplasms - surgery
Male
MEDICINE
Medicine & Public Health
METASTASES
Middle Aged
Minimally Invasive Surgical Procedures - methods
Multivariate Analysis
Neoplasm Staging
Nuclear Medicine
ORGANS
Predictive Value of Tests
Quality of Life
RADIATIONS
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
RADIOWAVE RADIATION
Retrospective Studies
Risk Assessment
SURGERY
Survival Analysis
SURVIVAL TIME
Treatment Outcome
Ultrasound
title Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A16%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiofrequency%20Ablation%20of%20Colorectal%20Liver%20Metastases:%20Small%20Size%20Favorably%20Predicts%20Technique%20Effectiveness%20and%20Survival&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Veltri,%20Andrea&rft.date=2008-09-01&rft.volume=31&rft.issue=5&rft.spage=948&rft.epage=956&rft.pages=948-956&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-008-9362-0&rft_dat=%3Cproquest_osti_%3E69541564%3C/proquest_osti_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=227342119&rft_id=info:pmid/18506519&rfr_iscdi=true